Hostname: page-component-89b8bd64d-nlwjb Total loading time: 0 Render date: 2026-05-08T04:05:22.581Z Has data issue: false hasContentIssue false

A high-amylopectin diet caused hepatic steatosis associated with more lipogenic enzymes and increased serum insulin concentration

Published online by Cambridge University Press:  01 June 2011

Jun He*
Affiliation:
Institute of Animal Nutrition, Sichuan Agricultural University, Yaan, Sichuan 625014, People's Republic of China Key Laborotary of Animal Disease-Resistance Nutrition, Ministry of Education, People's Republic of China
Daiwen Chen
Affiliation:
Institute of Animal Nutrition, Sichuan Agricultural University, Yaan, Sichuan 625014, People's Republic of China Key Laborotary of Animal Disease-Resistance Nutrition, Ministry of Education, People's Republic of China
Keying Zhang
Affiliation:
Institute of Animal Nutrition, Sichuan Agricultural University, Yaan, Sichuan 625014, People's Republic of China Key Laborotary of Animal Disease-Resistance Nutrition, Ministry of Education, People's Republic of China
Bing Yu
Affiliation:
Institute of Animal Nutrition, Sichuan Agricultural University, Yaan, Sichuan 625014, People's Republic of China Key Laborotary of Animal Disease-Resistance Nutrition, Ministry of Education, People's Republic of China
*
*Corresponding author: J. He, fax +86 835 2885164, email hejun8067@163.com
Rights & Permissions [Opens in a new window]

Abstract

Starch is the major energy source for monogastric mammals and humans. The present study was conducted to evaluate the liver metabolic responses of weaned pigs fed with different dietary starches. A total of sixteen weaned pigs were fed with two experimental diets containing either cassava starch (CS, 80 % amylopectin and 20 % amylose) or maize starch (70 % amylopectin and 30 % amylose). The present results showed that the growth performance was not affected by different dietary starches (P>0·05). However, ingestion of CS not only increased the lipid content in liver tissues, but also elevated the concentrations of serum cholesterol and insulin (P < 0·05). The metabolic responses induced by CS were associated with more lipogenic enzymes such as fatty acid synthase and 3-hydroxy-3-methyl-glutaryl-CoA reductase in liver (P < 0·05). Real-time PCR quantification for lipid metabolic genes indicated that ingestion of CS not only up-regulated the expression of these lipogenic genes, but also decreased the expression of lipolytic genes. These results suggested that the metabolic responses of weaned pigs fed with different dietary starches may vary widely depending on their composition, and ingestion of starches that are high in amylopectin may produce a stronger insulinaemic response and lead to an up-regulation of lipogenesis in the liver.

Information

Type
Full Papers
Copyright
Copyright © The Authors 2011
Figure 0

Table 1 Ingredient and chemical composition of experimental diets (as fed-basis)

Figure 1

Table 2 Primer sequences of genes selected for analysis by real-time RT-PCR

Figure 2

Table 3 Effects of different dietary starches on growth performance, metabolic hormones and hepatic lipid concentrations in weaned pigs(Mean values with their standard errors)

Figure 3

Fig. 1 Effect of different dietary starches on serum glucose and lipid concentrations. Mean values were significantly different: *P < 0·05, † P < 0·10. , Cassava starch (CS); □, maize starch (MS).

Figure 4

Fig. 2 Effect of different dietary starches on the activities of lipid metabolic enzymes. Mean values were significantly different: *P < 0·05, † P < 0·10. , cassava starch (CS); □, maize starch (MS). G6PD, glucose-6-phosphate dehydrogenase; FAS, fatty acid synthase; ACOX1, acyl-CoA oxidase 1; HMGR, HMG-CoA reductase.

Figure 5

Fig. 3 Effect of different dietary starches on hepatic gene expression. The relative expression was calculated as the ratio of target gene to internal reference gene. Mean values were significantly different: *P < 0·05; **P < 0·01. , Cassava starch; □, maize starch; fasn, fatty acid synthase; hmgr, 3-hydroxy-3-methylglutaryl-coenzyme A reductase; acox1, acyl-CoA oxidase 1; cpt1a, carnitine palmitoyltransferase 1A; dgat, diacylglycerol acyltransferase.